Andere talen Silence Therapeutics plc

Aandelen

SLN

US82686Q1013

Biotechnologie & Medisch Onderzoek

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 20-06-2025			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
5,950 ^USD	+5,12%		+11,63%	-13,52%

17/06	Europese aandelen verhandeld als Amerikaanse depositary receipts dalen op dinsdag	MT
12/06	Silence Therapeutics zegt dat het profiel van Diversiran 'aantrekkelijk' blijft in bijgewerkte gegevens	MT

Andere talen

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading	17/06
Silence Therapeutics Says Diversiran Profile Remains 'Compelling' in Updated Data	12/06
Silence Therapeutics plc Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-In-Class Sirna Treatment for Polycythemia Vera	12/06
Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera	12/06
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	02/06
European Equities Traded in the US as American Depositary Receipts Surge Higher in Tuesday Trading	27/05
European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading	22/05
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	21/05
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Up 1.4% for Week	16/05
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading	13/05
Top Premarket Gainers	13/05
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	12/05
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Down 1% for Week	09/05
European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading	08/05
Silence Therapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2025	08/05
Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights	08/05
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	07/05
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	06/05
Silence Therapeutics plc Announces Board and Committee Changes	06/05
Silence Therapeutics Welcomes Tim McInerney to Board of Directors	06/05
European Equities Traded in the US as American Depositary Receipts Marginally Higher in Monday Trading	05/05
European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading	01/05
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading	28/04
European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading	21/04
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	14/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripten Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Silence Therapeutics plc

Aandelen

SLN

US82686Q1013

Biotechnologie & Medisch Onderzoek

Andere talen

Filters